These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23335290)

  • 21. Clinical and economic implications of topical cyclosporin A for the treatment of dry eye.
    Cross WD; Lay LF; Walt JG; Kozma CM
    Manag Care Interface; 2002 Sep; 15(9):44-9. PubMed ID: 12244650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
    Kujawa A; Rózycki R
    Klin Oczna; 2005; 107(4-6):280-6. PubMed ID: 16118939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dry eye symptoms following cataract surgery.
    Roberts CW; Elie ER
    Insight; 2007; 32(1):14-21; quiz 22-3. PubMed ID: 17533782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a new topical cationic emulsion of cyclosporine A on dry eye clinical signs in an experimental mouse model of dry eye.
    Daull P; Feraille L; Barabino S; Cimbolini N; Antonelli S; Mauro V; Garrigue JS
    Exp Eye Res; 2016 Dec; 153():159-164. PubMed ID: 27777121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction.
    Prabhasawat P; Tesavibul N; Mahawong W
    Cornea; 2012 Dec; 31(12):1386-93. PubMed ID: 23135530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%.
    Malta JB; Soong HK; Shtein RM; Musch DC; Rhoades W; Sugar A; Mian SI
    Cornea; 2010 Dec; 29(12):1392-6. PubMed ID: 20847658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ophthalmic cyclosporine use in ocular GVHD.
    Lelli GJ; Musch DC; Gupta A; Farjo QA; Nairus TM; Mian SI
    Cornea; 2006 Jul; 25(6):635-8. PubMed ID: 17077652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of topical cyclosporine A treatment on corneal thickness in patients with trachomatous dry eye.
    Guzey M; Satici A; Karaman SK; Ordulu F; Sezer S
    Clin Exp Optom; 2009 Jul; 92(4):349-55. PubMed ID: 19473348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Considerations in the pharmacoeconomics of dry eye.
    Hirsch JD
    Manag Care; 2003 Dec; 12(12 Suppl):33-8. PubMed ID: 14723112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical cyclosporine in thyroid orbitopathy-related dry eye: clinical findings, conjunctival epithelial apoptosis, and MMP-9 expression.
    Gürdal C; Genç I; Saraç O; Gönül I; Takmaz T; Can I
    Curr Eye Res; 2010 Sep; 35(9):771-7. PubMed ID: 20795858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporine 0.05% ophthalmic emulsion for dry eye in Korea: a prospective, multicenter, open-label, surveillance study.
    Byun YS; Rho CR; Cho K; Choi JA; Na KS; Joo CK
    Korean J Ophthalmol; 2011 Dec; 25(6):369-74. PubMed ID: 22131772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye.
    Sall KN; Cohen SM; Christensen MT; Stein JM
    Eye Contact Lens; 2006 Jan; 32(1):21-6. PubMed ID: 16415689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of cyclosporine 0.05% eye drops in Stevens Johnson syndrome with chronic dry eye.
    Prabhasawat P; Tesavibul N; Karnchanachetanee C; Kasemson S
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):372-7. PubMed ID: 23289903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
    Kim EC; Choi JS; Joo CK
    Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical 0.05% cyclosporin in the treatment of dry eye.
    Perry HD; Donnenfeld ED
    Expert Opin Pharmacother; 2004 Oct; 5(10):2099-107. PubMed ID: 15461545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome.
    Brown MM; Brown GC; Brown HC; Peet J; Roth Z
    Arch Ophthalmol; 2009 Feb; 127(2):146-52. PubMed ID: 19204231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keratitis in Dry Eye Disease and Topical Ciclosporin A.
    Leonardi A; Flamion B; Baudouin C
    Ocul Immunol Inflamm; 2017 Aug; 25(4):577-586. PubMed ID: 28146363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of topical cyclosporine 0.05% on dry eye after cataract surgery.
    Chung YW; Oh TH; Chung SK
    Korean J Ophthalmol; 2013 Jun; 27(3):167-71. PubMed ID: 23730108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation and management of post-LASIK dry eye syndrome.
    Rosenfeld SI
    Int Ophthalmol Clin; 2010; 50(3):191-9. PubMed ID: 20611028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.